The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase II randomized trial of pembrolizumab versus cetuximab, concomitant with radiotherapy (RT) in locally advanced (LA) squamous cell carcinoma of the head and neck (SCCHN): First results of the GORTEC 2015-01 “PembroRad” trial.
 
Xu Shan Sun
No Relationships to Disclose
 
Christian Sire
No Relationships to Disclose
 
Yungan Tao
No Relationships to Disclose
 
Laurent Martin
No Relationships to Disclose
 
Marc Alfonsi
No Relationships to Disclose
 
Jean Briac Prevost
No Relationships to Disclose
 
Michel Rives
No Relationships to Disclose
 
Cedrik Lafond
No Relationships to Disclose
 
Jean-Marc Tourani
No Relationships to Disclose
 
Julian Biau
No Relationships to Disclose
 
Lionnel Geoffrois
No Relationships to Disclose
 
Alexandre Coutte
No Relationships to Disclose
 
Xavier Liem
No Relationships to Disclose
 
Elodie Vauleon
No Relationships to Disclose
 
Franck Drouet
No Relationships to Disclose
 
Jean-François Ramee
No Relationships to Disclose
 
Gabriel Waksi
No Relationships to Disclose
 
Laura Sinigaglia
No Relationships to Disclose
 
Anne Auperin
No Relationships to Disclose
 
Jean Bourhis
No Relationships to Disclose